[Active enhancement using B-lymphocytes].
B-lymphocytes given 7 days prior to auxiliary heterotopic heart transplantation significantly delay transplant rejection. T-lymphocytes or purified erythrocytes have no effect at all on the subsequent heart graft. The beneficial effect of blood transfusions could be due to the transfusion of B-lymphocytes, which create a state of active enhancement in the transplant recipient.
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology*; D001803:Blood Transfusion; D006084:Graft Rejection; D016027:Heart Transplantation; D007111:Immunity, Cellular; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013601:T-Lymphocytes / Q000276:immunology; D014183:Transplantation, Heterologous
Aktives Enhancement durch B-Lymphocyten.